Table S1.
Complete list of psychotropic medications included in the covariate assessment
| Drugs | Drugs |
|---|---|
| Benzodiazepines | Antidepressants |
| Alprazolam | Maprotiline |
| Bromazepam | Mianserin |
| Brotizolam | Milnacipran |
| Chlordiazepoxide | Mirtazapine |
| Clobazam | Nortriptyline |
| Clonazepam | Paroxetine |
| Clorazepate dipotassium | Sertraline |
| Clotiazepam | Setiptiline |
| Cloxazolam | Sulpirideb |
| Diazepam | Trazodone |
| Estazolam | Trimipramine |
| Eszopiclone | Antipsychotics |
| Ethyl loflazepate | Aripiprazole |
| Etizolam | Blonanserin |
| Fludiazepam | Bromperidol |
| Flunitrazepam | Carpipramine |
| Flurazepam | Chlorpromazine |
| Flutazolam | Chlorpromazine–promethazine–phenobarbitala |
| Flutoprazepam | Clocapramine |
| Haloxazolam | Clozapine |
| Lorazepam | Fluphenazine |
| Lormetazepam | Haloperidol |
| Medazepam | Haloperidol decanoate |
| Mexazolam | Levomepromazine |
| Nimetazepam | Mosapramine |
| Nitrazepam | Nemonapride |
| Oxazolam | Olanzapine |
| Quazepam | Oxypertine |
| Rilmazafone | Paliperidone |
| Tofisopam | Paliperidone palmitate |
| Triazolam | Perospirone |
| Zolpidem | Perphenazine |
| Zopiclone | Pimozide |
| Barbiturates | Pipamperone |
| Amobarbital | Prochlorperazine |
| Barbital | Propericiazine |
| Chlorpromazine–promethazine–phenobarbitala | Quetiapine |
| Pentobarbital calcium | Reserpine |
| Phenobarbital | Risperidone |
| Phenobarbital sodium | Spiperone |
| Phenytoin–phenobarbital | Sulpirideb |
| Secobarbital sodium | Sultopride |
| Antidepressants | Tiapride |
| Amitriptyline | Timiperone |
| Amoxapine | Trifluoperazine |
| Clomipramine | Zotepine |
| Dosulepin | Stabilizers |
| Duloxetine | Carbamazepine |
| Escitalopram | Lamotrigine |
| Fluvoxamine | Lithium |
| Imipramine | Valproate |
| Lofepramine |
Notes:
a
Chlorpromazine–promethazine–phenobarbital combined was double-counted as both a barbiturate and an antipsychotic.
b
Sulpiride of <300 or ≥300 mg/day was counted as an antidepressant or an antipsychotic, respectively.